U.S. Heart Failure Therapeutics Markets

 

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

Table of Contents

U.S. Heart Failure Therapeutics Markets, Executive SummaryExecutive SummaryExecutive SummaryU.S. Heart Failure Therapeutics Markets, Introduction to Heart FailureIntroduction to Heart FailureIntroduction to Heart FailureMarket OverviewScope and SegmentationResearch MethodologyBasic Heart Failure Terminologies and DefinitionsHeart Failure DefinitionHeart Failure ClassificationHeart Failure EtiologyHeart Failure DiagnosisHeart Failure GlossaryU.S. Heart Failure Therapeutics Markets, U.S. Heart Failure Therapeutic Market SegmentsDisease and Treatment OverviewHeart Failure Incidence/Mortality and HospitalizationHeart Failure Prevalence ForecastHeart Failure Diagnosed and Treated Patient ForecastsHeart Failure Comorbid ConditionsPolypharmacy in Heart FailureHeart Failure Patient ComplianceProduct AnalysisOverviewImpact of Medical Devices on the Pharmaceutical MarketCurrent Status of Pharmacotherapy in Heart Failure ManagementAngiotensin Converting Enzyme InhibitorsAngiotensin Receptor BlockersBeta BlockersAldosterone AntagonistsOther Heart Failure TherapiesCombination TherapyU.S. Heart Failure Therapeutics Markets, U.S. Heart Failure Therapeutic MarketsMarket OverviewIntroductionIndustry ChallengesStrategic RecommendationsMarket DriversMarket RestraintsMarket Engineering MeasurementsMarket ForecastsRevenue ForecastsPricing TrendsKey Patent ExpirationsCompetitive and Product AnalysisCompetitive LandscapeLandmark StudiesSWOT Analysis of Current MedicationsCompetitor ProfilesPipeline AnalysisAnticipated Launch DatesFrost & Sullivan AwardsProduct Line Strategy of the Year AwardIndustry Innovation Advancement of the Year AwardTechnology Innovation of the Year AwardProduct Differentiation Innovation of the Year AwardU.S. Heart Failure Therapeutics Markets, AppendixDecision Support DatabasesCardiologistsCoronary Heart Disease MortalityHypertension PrevalenceMyocardial Infarction IncidenceMyocardial Infarction Mortality




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 13-Dec-17

Region : North America

Release Date : 13-Dec-17

Region : North America

Release Date : 12-Dec-17

Region : North America

Release Date : 12-Dec-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.